ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Live AUROPHARMA 1280.00 CE (CALL) 27 January 2026 options price chart analysis Aurobindo Pharma Limited

Live Options premium chart analysis for Live AUROPHARMA 1280.00 CE (CALL) 27 January 2026 options price chart analysis Aurobindo Pharma Limited

Aurobindo Pharma Limited AUROPHARMA trades in NSE under Pharmaceuticals NSE

AUROPHARMA 1280.00 CE Live prices

What is premium price of AUROPHARMA 1280.00 CE CALL today?
Premium of AUROPHARMA 1280.00 CE is 12.60 on 15 Dec 2025 CALL opened at 0.00 and traded inside a Low-High range of 0.00-0.00 today. Please click here table for more current prices.
What is open interest of AUROPHARMA 1280.00 CALL CE today?
Open Interest of AUROPHARMA 1280.00 CE is 4950 today. This has changed 0.00 from previous day.
What is underlying price of AUROPHARMA 1280.00 CE CALL today?
Underlying price of AUROPHARMA 1280.00 CE CALL is 1186.30 today.
What is lot size of AUROPHARMA 1280.00 CALL CE today?
Lot size of AUROPHARMA 1280.00 CALL CE is 550.00
Is AUROPHARMA 1280.00 CE CALL ITM or OTM or ATM?
AUROPHARMA 1280.00 CALL CE is OTM CALL option (out of the money). Only ITM options have intrinsic value in them, while OTM options have only time value in them.

Underlying equity prev closing: 1186.30

AUROPHARMA CALL CE available options strikes

CE 1140, CE 1160, CE 1180, CE 1200, CE 1220, CE 1240, All CE , All PE

AUROPHARMA 1280.00 CALL CE available expiry dates

30 Dec 202527 Jan 202624 Feb 2026

Premium of AUROPHARMA 1280.00 CALL CE January 27 2026

AUROPHARMA 1280.00 CE Live prices

Premium of CALL (CE) of strike 1280.00 is at: 12.60 on 15 Dec 2025
CALL opened at 0.00 and traded inside a Low-High range of 0.00-0.00 as on 15 Mon Dec 2025

The underlying equity is trading at 1186.30 which means that CALL of strike 1280.00 is OTM CALL option (out of the money)

Lot size of AUROPHARMA Aurobindo Pharma Limited is 550

Total Open Interest for CALL (CE) of strike 1280.00 is 4,950

Price action analysis of 1280.00 CALL based on a short term time period is neutral. A longer time frame might give a better analysis.

Price action analysis of 1280.00 CALL based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Click here to view most profitable CE and PE for Aurobindo Pharma Limited, both for buyers and sellers | AUROPHARMA Most Active Call Put Options

Date Underlying price CE price CE open CE high CE low CE volume CE OI OI Change
15 Mon Dec 1186.30 12.60 0.00 0.00 0.00 0 2,722,500 0%
12 Fri Dec 1195.10 12.60 0.00 0.00 0.00 0 2,722,500 0%
11 Thu Dec 1172.20 12.60 0.00 0.00 0.00 0 2,722,500 0%
10 Wed Dec 1172.60 12.60 0.00 0.00 0.00 0 2,722,500 0%
09 Tue Dec 1163.60 12.60 13.00 13.00 12.55 -21 2,722,500 28.6%
08 Mon Dec 1177.40 16.00 16.50 16.50 15.20 -37 2,117,500 -12.5%

Charts for AUROPHARMA 1280.00 CALL CE options for Aurobindo Pharma Limited

Select an expiry and a strike price below to view charts for those options. AUROPHARMA All in One charts

Charts for:      

Dark shadowed line on the chart below is the current SPOT price line of underlying equity. White line on the chart is the option closing price line. Candle sticks on the chart are the OHLC for the option.

Live AUROPHARMA 1280.00 CE (CALL) 27 January 2026 options price chart analysis Aurobindo Pharma Limited

AUROPHARMA further analysis

Live AUROPHARMA 1280.00 CE (CALL) 27 January 2026 options price chart analysis Aurobindo Pharma Limited

These are Live AUROPHARMA 1280.00 CE (CALL) 27 January 2026 options price chart analysis Aurobindo Pharma Limited . Click the links below to switch between charts

 

Videos related to: Live AUROPHARMA 1280.00 CE (CALL) 27 January 2026 options price chart analysis Aurobindo Pharma Limited

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Live AUROPHARMA 1280.00 CE (CALL) 27 January 2026 options price chart analysis Aurobindo Pharma Limited

 

Back to top